Targeting Atg4B for cancer therapy: Chemical mediators

Eur J Med Chem. 2021 Jan 1:209:112917. doi: 10.1016/j.ejmech.2020.112917. Epub 2020 Oct 11.

Abstract

Atg4, a pivotal macroautophagy/autophagy-related cysteine protein family, which regulate autophagy through either cleaving Atg8 homologs for its further lipidation or delipidating Atg8 homologs from the autophagosome. There are four homologs, Atg4A, Atg4B, Atg4C, and Atg4D. Among them, an increasing amount of evidence indicates that Atg4B possessed superior catalytic efficiency toward the Atg8 substrate, as well as regulates autophagy process and plays a key role in the development of several human cancers. Recently, efforts have been contributed to the exploration of Atg4B inhibitors or activators. In this review, we comprehensively clarify the function of Atg4B in autophagy and cancer biology, as well as the relationship between pharmacological function and structure-activity of small molecule drugs targeting Atg4B. The development of novel drugs targeting Atg4B could be well applied in the clinical practice.

Keywords: Autophagy; Cancer; Drug target; Small molecule modulators; atg4B.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Autophagy / drug effects
  • Autophagy-Related Proteins / antagonists & inhibitors*
  • Chloroquine / pharmacology
  • Cysteine Endopeptidases
  • Cysteine Proteinase Inhibitors / chemistry*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Drug Screening Assays, Antitumor
  • Drug Therapy, Combination
  • Humans
  • Imidazoles / pharmacology
  • Models, Molecular
  • Molecular Targeted Therapy
  • Protein Binding
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Antineoplastic Agents
  • Autophagy-Related Proteins
  • Cysteine Proteinase Inhibitors
  • Imidazoles
  • Chloroquine
  • ATG4B protein, human
  • Cysteine Endopeptidases
  • tioconazole